← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 1, 2016Last known activity
Dec 1, 2025
Timeline
2010s
- Jun 1, 2016
Hebei Senlang Biotechnology Inc., Ltd.— Founded
Drugs by trial phase (20 distinct, 40 trials)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (11 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Recent trials (40)
- NCT07234721CollaboratorEarly Phase 1Dec 1, 2025
- NCT07244380Lead sponsorPhase 2Nov 28, 2025
- NCT07161193Lead sponsorPhase 1/Phase 2Sep 30, 2025
- NCT06874946CollaboratorPhase 1/Phase 2Feb 14, 2025
- NCT07244406Lead sponsorPhase 2Jan 10, 2025
- NCT06880913CollaboratorPhase 1/Phase 2Nov 14, 2024
- NCT06067581Lead sponsorEarly Phase 1Aug 21, 2023
- NCT06136364Lead sponsorPhase 1Aug 15, 2023
- NCT05626400Lead sponsorN/AAug 29, 2022
- NCT05398614Lead sponsorPhase 1May 1, 2022
- NCT05388695Lead sponsorPhase 1Apr 8, 2022
- NCT05333588Lead sponsorEarly Phase 1Feb 15, 2022
- NCT05225831Lead sponsorEarly Phase 1Aug 15, 2021
- NCT04938115Lead sponsorN/AMay 10, 2021
- NCT05206071Lead sponsorN/AMay 1, 2021
Details
- Founded
- Hebei, CN Jun 1, 2016
- Last known activity
- Dec 1, 2025